Jun 24 |
Nuvalent: Making Precise Progress In Its Oncology Pipeline
|
Jun 14 |
Nuvalent: NVL-655 Could Bring Blockbuster Potential
|
Jun 9 |
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
|
May 29 |
Nuvalent to Participate in the 2024 Jefferies Global Healthcare Conference
|
May 17 |
FDA grants breakthrough therapy status for Nuvalent’s NVL-655
|
May 16 |
Nuvalent gains breakthrough therapy status for non-small cell lung cancer candidate
|
May 16 |
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655
|
Apr 5 |
Chief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)
|
Apr 5 |
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
|
Mar 25 |
Chief Development Officer Darlene Noci Sells 20,000 Shares of Nuvalent Inc (NUVL)
|